New study cautions transgender women and physicians to approach standard screening guidelines with caution. Hormone therapy in transgender women can...
Vous n'êtes pas connecté
Study finds that transgender women on hormone therapy may have early-stage prostate cancer missed by current PSA screening guidelines.
New study cautions transgender women and physicians to approach standard screening guidelines with caution. Hormone therapy in transgender women can...
MONDAY, July 1, 2024 -- Current screening standards could miss early-stage prostate cancer in transgender women, a new study warns. Prostate cancer...
Current prostate cancer tests may fail to detect early-stage disease in transgender women, potentially leading to delayed diagnosis and treatment.
Transgender women continue to face the risk of developing prostate cancer. A recent study conducted by Cedars-Sinai Cancer researchers, published in...
A recent study published in the Journal of the American Medical Association (JAMA) has shed new light on prostate-specific antigen (PSA) values among...
Breast cancer is a complex disease with varying degrees of severity and treatment approaches. Central to understanding and managing breast cancer is...
UCSF-led study alerts transwomen and physicians to interpret standard screening guidelines with caution.
More than 85% of women – and more than 300 million people worldwide at any given time – use hormonal contraceptives for at least five years of...
A comprehensive analysis of data from nearly 400,000 healthy U.S. adults over more than 20 years has found no association between regular multivitamin...
A research effort led by Dean Tang, PhD, of Roswell Park Comprehensive Cancer Center, USA, sheds light on a critical area of oncologic study — the...